Next Article in Journal
Omics-based Investigation of Diet-induced Obesity Synergized with HBx, Src, and p53 Mutation Accelerating Hepatocarcinogenesis in Zebrafish Model
Previous Article in Journal
FOXD1 and Gal-3 Form a Positive Regulatory Loop to Regulate Lung Cancer Aggressiveness
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Addendum

Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578

Institute of Cell Biology (Cancer Research), University Hospital Essen, 45122 Essen, Germany
*
Author to whom correspondence should be addressed.
Cancers 2019, 11(12), 1898; https://doi.org/10.3390/cancers11121898
Submission received: 20 November 2019 / Accepted: 22 November 2019 / Published: 28 November 2019
The authors would like to make an addendum to their published paper [1].
There was a missing annotation and reference in the original version of the article in the caption of Figure 1 in [1]:
The authors wish to mention that some elements from Figure 1 are inspired from Salmi and Jalkanen [2] and modified from Cappuccini, “Radiation-induced pneumonitis and fibrosis—Defining the role of immune cells and regulatory molecules” (Ph.D. thesis) [3].
The changes do not affect the scientific results.
The rest of the manuscript does not need to be changed. The authors would like to apologize for any inconvenience caused.

References

  1. De Leve, S.; Wirsdorfer, F.; Jendrossek, V. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578. [Google Scholar] [CrossRef] [PubMed]
  2. Salmi, M.; Jalkanen, S. Cell-surface enzymes in control of leukocyte trafficking. Nat. Rev. Immunol. 2005, 5, 760–771. [Google Scholar] [CrossRef] [PubMed]
  3. Cappuccini, F. Radiation-induced pneumonitis and fibrosis—Defining the role of immune cells and regulatory molecules. Ph.D. Thesis, University Duisburg-Essen, Essen, Germany, 2017. [Google Scholar]

Share and Cite

MDPI and ACS Style

de Leve, S.; Wirsdörfer, F.; Jendrossek, V. Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578. Cancers 2019, 11, 1898. https://doi.org/10.3390/cancers11121898

AMA Style

de Leve S, Wirsdörfer F, Jendrossek V. Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578. Cancers. 2019; 11(12):1898. https://doi.org/10.3390/cancers11121898

Chicago/Turabian Style

de Leve, Simone, Florian Wirsdörfer, and Verena Jendrossek. 2019. "Addendum: de Leve, S.; et al. The CD73/Ado System—A New Player in RT Induced Adverse Late Effects. Cancers 2019, 11, 1578" Cancers 11, no. 12: 1898. https://doi.org/10.3390/cancers11121898

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop